Cargando…

Correction: MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancer

Detalles Bibliográficos
Autores principales:	Lagendijk, Mirelle, Saadatmand, Sepideh, Koppert, Linetta B., Tilanus-Linthorst, Madeleine M.A., de Weerd, Vanja, Ramírez-Moreno, Raquel, Smid, Marcel, Sieuwerts, Anieta M., Martens, John W.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112841/ https://www.ncbi.nlm.nih.gov/pubmed/30174799 http://dx.doi.org/10.18632/oncotarget.25979

Ejemplares similares

MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancer
por: Lagendijk, Mirelle, et al.
Publicado: (2018)

Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173 797 patients
por: Saadatmand, Sepideh, et al.
Publicado: (2015)

Mitochondrial DNA content in breast cancer: Impact on in vitro and in vivo phenotype and patient prognosis
por: Weerts, Marjolein J.A., et al.
Publicado: (2016)

Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial
por: Saadatmand, Sepideh, et al.
Publicado: (2012)

Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer
por: Yu, Jack X, et al.
Publicado: (2007)

APOBEC3B Gene Expression in Ductal Carcinoma In Situ and Synchronous Invasive Breast Cancer
por: Sieuwerts, Anieta M., et al.
Publicado: (2019)

High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes
por: Riaz, Muhammad, et al.
Publicado: (2012)

Clinical significance of the nuclear receptor co-regulator DC-SCRIPT in breast cancer: an independent retrospective validation study
por: Sieuwerts, Anieta M, et al.
Publicado: (2010)

DC-SCRIPT is a novel regulator of the tumor suppressor gene CDKN2B and induces cell cycle arrest in ERα-positive breast cancer cells
por: Ansems, Marleen, et al.
Publicado: (2015)

T lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expression
por: Mustafa, Dana A. M., et al.
Publicado: (2018)

ER and PI3K Pathway Activity in Primary ER Positive Breast Cancer Is Associated with Progression-Free Survival of Metastatic Patients under First-Line Tamoxifen
por: M. Sieuwerts, Anieta, et al.
Publicado: (2020)

Quality of life of caregivers of breast cancer patients: a cross-sectional evaluation
por: Clarijs, Marloes E., et al.
Publicado: (2022)

Progressive APOBEC3B mRNA expression in distant breast cancer metastases
por: Sieuwerts, Anieta M., et al.
Publicado: (2017)

Correction: Quality of life of caregivers of breast cancer patients: a cross-sectional evaluation
por: Clarijs, Marloes E., et al.
Publicado: (2022)

Proteomic characterization of microdissected breast tissue environment provides a protein‐level overview of malignant transformation
por: Braakman, René B. H., et al.
Publicado: (2017)

Association of microRNA-7 and its binding partner CDR1-AS with the prognosis and prediction of 1(st)-line tamoxifen therapy in breast cancer
por: Uhr, K., et al.
Publicado: (2018)

Molecular characteristics of circulating tumor cells resemble the liver metastasis more closely than the primary tumor in metastatic colorectal cancer
por: Onstenk, Wendy, et al.
Publicado: (2016)

A Method to Correlate mRNA Expression Datasets Obtained from Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Tissue Samples: A Matter of Thresholds
por: Mustafa, Dana A. M., et al.
Publicado: (2015)

CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations
por: Redis, Roxana S, et al.
Publicado: (2013)

Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast Cancer
por: Dalm, Simone U., et al.
Publicado: (2017)

Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer
por: De Marchi, Tommaso, et al.
Publicado: (2017)

Experiences, expectations and preferences regarding MRI and mammography as breast cancer screening tools in women at familial risk
por: Geuzinge, H. Amarens, et al.
Publicado: (2021)

Breast and Tumour Volume Measurements in Breast Cancer Patients Using 3-D Automated Breast Volume Scanner Images
por: Lagendijk, M., et al.
Publicado: (2018)

A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast
por: Van Bockstal, Mieke R., et al.
Publicado: (2019)

Comparative Proteome Analysis Revealing an 11-Protein Signature for Aggressive Triple-Negative Breast Cancer
por: Liu, Ning Qing, et al.
Publicado: (2014)

A preliminary prediction model for potentially guiding patient choices between breast conserving surgery and mastectomy in early breast cancer patients; a Dutch experience
por: Vos, Elvira, et al.
Publicado: (2017)

Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study
por: Hsieh, Szu-Min, et al.
Publicado: (2009)

Machine learning with PROs in breast cancer surgery; caution: Collecting PROs at baseline is crucial
por: van Egdom, Laurentine S. E., et al.
Publicado: (2020)

Anti-Epithelial Cell Adhesion Molecule Antibodies and the Detection of Circulating Normal-Like Breast Tumor Cells
por: Sieuwerts, Anieta M., et al.
Publicado: (2009)

The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer
por: Liu, Jingjing, et al.
Publicado: (2016)

BREAST-Q Breast-Conserving Therapy Module: Normative Data from a Dutch Sample of 9059 Women
por: Oemrawsingh, Arvind, et al.
Publicado: (2022)

Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor()
por: Beije, Nick, et al.
Publicado: (2016)

Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age
por: Drooger, Jan C., et al.
Publicado: (2015)

Confirmation of a metastasis-specific microRNA signature in primary colon cancer
por: Coebergh van den Braak, Robert R. J, et al.
Publicado: (2018)

Opportunities for personalised follow‐up care among patients with breast cancer: A scoping review to identify preference‐sensitive decisions
por: de Ligt, Kelly M., et al.
Publicado: (2019)

Gene length corrected trimmed mean of M-values (GeTMM) processing of RNA-seq data performs similarly in intersample analyses while improving intrasample comparisons
por: Smid, Marcel, et al.
Publicado: (2018)

The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer
por: Vitale, Silvia R., et al.
Publicado: (2022)

Radioactive Seed Versus Wire-Guided Localization for Ductal Carcinoma in Situ of the Breast: Comparable Resection Margins
por: Agahozo, Marie Colombe, et al.
Publicado: (2020)

The circular RNome of primary breast cancer
por: Smid, Marcel, et al.
Publicado: (2019)

Generation of in situ sequencing based OncoMaps to spatially resolve gene expression profiles of diagnostic and prognostic markers in breast cancer
por: Svedlund, Jessica, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d3km29q4lqt2cmknphc0hpvga0